Shivinder Mohan Singh is an Indian business man and erstwhile billionaire with Fortis Healthcare, Religare and Ranbaxy Laboratories. Singh was the non-executive vice chairman of Fortis Healthcare, an Indian company.
A Delhi court on Thursday sent former Fortis Healthcare promoter Shivinder Singh to judicial custody till January 8 in connection with the RFL money laundering case.
A Delhi court on Friday sent former Fortis Healthcare promoter Shivinder Mohan Singh to the custody of the Enforcement Directorate (ED) till December 19 in a money laundering case related to alleged misappropriation of funds at Religare Finvest Ltd (RFL).
A Delhi court on Thursday rejected the bail plea of former Ranbaxy promoter Shivinder Singh in connection with a case related to alleged misappropriation of funds at Religare Finvest Limited.
Fortis Healthcare on Monday said that it is exploring legal means in response to the Supreme Court's order last week which held the company guilty of contempt.
The Supreme Court on Friday held former Ranbaxy promoters, Malvinder and Shivinder Singh, guilty of contempt for violating the order directing the duo to not divest their shares in Fortis Healthcare Ltd.
Rs 1,260 crore has been diverted to Malvinder Singh's firm RHC Holdings Pvt Ltd in order to square off liabilities, the Economic Offences Wing (EOW) probing the Religare Fraud Case told a Delhi Court.
Former promoters of pharmaceutical giant Ranbaxy, Shivinder Singh and his elder brother Malvinder Singh, have been arrested in a Rs 740 crore fraud case, sources said.
Religare Enterprises Ltd (REL), a financial services group, has entered into a share purchase agreement (SPA) for sale of its NBFC business Religare Finvest to TCG Advisory Services for Rs 330 crore.
The Enforcement Directorate (ED) on Thursday raided the residential premises of former Ranbaxy CEO Malvinder Mohan Singh and his brother Shivinder Singh in connection with a money laundering case.